Literature DB >> 23555187

γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown.

Emily Diane Wickline1, Yu Du, Donna B Stolz, Michael Kahn, Satdarshan P S Monga.   

Abstract

β-Catenin is important in liver homeostasis as a part of Wnt signaling and adherens junctions (AJs), while its aberrant activation is observed in hepatocellular carcinoma (HCC). We have reported hepatocyte-specific β-catenin knockout (KO) mice to lack adhesive defects as γ-catenin compensated at AJ. Because γ-catenin is a desmosomal protein, we asked if its increase in KO might deregulate desmosomes. No changes in desmosomal proteins or ultrastructure other than increased plakophilin-3 were observed. To further elucidate the role and regulation of γ-catenin, we contemplate an in vitro model and show γ-catenin increase in HCC cells upon β-catenin knockdown (KD). Here, γ-catenin is unable to rescue β-catenin/T cell factor (TCF) reporter activity; however, it sufficiently compensates at AJs as assessed by scratch wound assay, centrifugal assay for cell adhesion (CAFCA), and hanging drop assays. γ-Catenin increase is observed only after β-catenin protein decrease and not after blockade of its transactivation. γ-Catenin increase is associated with enhanced serine/threonine phosphorylation and abrogated by protein kinase A (PKA) inhibition. In fact, several PKA-binding sites were detected in γ-catenin by in silico analysis. Intriguingly γ-catenin KD led to increased β-catenin levels and transactivation. Thus, γ-catenin compensates for β-catenin loss at AJ without affecting desmosomes but is unable to fulfill functions in Wnt signaling. γ-Catenin stabilization after β-catenin loss is brought about by PKA. Catenin-sensing mechanism may depend on absolute β-catenin levels and not its activity. Anti-β-catenin therapies for HCC affecting total β-catenin may target aberrant Wnt signaling without negatively impacting intercellular adhesion, provided mechanisms leading to γ-catenin stabilization are spared.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23555187      PMCID: PMC3612914          DOI: 10.1593/neo.122098

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  71 in total

Review 1.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

Review 2.  Involvement of cell junctions in hepatocyte culture functionality.

Authors:  Mathieu Vinken; Peggy Papeleu; Sarah Snykers; Evelien De Rop; Tom Henkens; James Kevin Chipman; Vera Rogiers; Tamara Vanhaecke
Journal:  Crit Rev Toxicol       Date:  2006-04       Impact factor: 5.635

3.  Leaky junctions and cholestasis: a tight correlation.

Authors:  J M Anderson
Journal:  Gastroenterology       Date:  1996-05       Impact factor: 22.682

4.  Posttranslational regulation of plakoglobin expression. Influence of the desmosomal cadherins on plakoglobin metabolic stability.

Authors:  A P Kowalczyk; H L Palka; H H Luu; L A Nilles; J E Anderson; M J Wheelock; K J Green
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

5.  E-cadherin and plakoglobin recruit plakophilin3 to the cell border to initiate desmosome assembly.

Authors:  Prajakta Gosavi; Samrat T Kundu; Nileema Khapare; Lalit Sehgal; Mansi S Karkhanis; Sorab N Dalal
Journal:  Cell Mol Life Sci       Date:  2010-09-23       Impact factor: 9.261

6.  Evaluation of the physical and in vitro protective activity of three synthetic peptides derived from the pro- and mature GDNF sequence.

Authors:  Kristen A Kelps; Jadwiga Turchan-Cholewo; Erin R Hascup; Tiffany L Taylor; Don M Gash; Greg A Gerhardt; Luke H Bradley
Journal:  Neuropeptides       Date:  2011-04-19       Impact factor: 3.286

7.  Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism.

Authors:  T A Haystead; A T Sim; D Carling; R C Honnor; Y Tsukitani; P Cohen; D G Hardie
Journal:  Nature       Date:  1989-01-05       Impact factor: 49.962

8.  Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling.

Authors:  Jifen Li; David Swope; Natalia Raess; Lan Cheng; Eliane J Muller; Glenn L Radice
Journal:  Mol Cell Biol       Date:  2011-01-18       Impact factor: 4.272

9.  A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].

Authors:  Katayoon H Emami; Cu Nguyen; Hong Ma; Dae Hoon Kim; Kwang Won Jeong; Masakatsu Eguchi; Randall T Moon; Jia-Ling Teo; Se Woong Oh; Hak Yeop Kim; Sung Hwan Moon; Jong Ryul Ha; Michael Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

10.  Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.

Authors:  I Simcha; M Shtutman; D Salomon; J Zhurinsky; E Sadot; B Geiger; A Ben-Ze'ev
Journal:  J Cell Biol       Date:  1998-06-15       Impact factor: 10.539

View more
  26 in total

1.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

2.  Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.

Authors:  Evan Delgado; Hirohisa Okabe; Morgan Preziosi; Jacquelyn Olivia Russell; Tamara Feliciano Alvarado; Michael Oertel; Kari Nichole Nejak-Bowen; Yixian Zhang; Satdarshan P S Monga
Journal:  J Hepatol       Date:  2014-10-18       Impact factor: 25.083

3.  Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.

Authors:  Wantae Kim; Sanjoy Kumar Khan; Jelena Gvozdenovic-Jeremic; Youngeun Kim; Jason Dahlman; Hanjun Kim; Ogyi Park; Tohru Ishitani; Eek-Hoon Jho; Bin Gao; Yingzi Yang
Journal:  J Clin Invest       Date:  2016-11-21       Impact factor: 14.808

4.  Mice with Hepatic Loss of the Desmosomal Protein γ-Catenin Are Prone to Cholestatic Injury and Chemical Carcinogenesis.

Authors:  Lili Zhou; Tirthadipa Pradhan-Sundd; Minakshi Poddar; Sucha Singh; Alex Kikuchi; Donna B Stolz; Weinian Shou; Zongfang Li; Kari N Nejak-Bowen; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2015-10-17       Impact factor: 4.307

5.  Dual ablation of β- and γ-catenin: Critical regulators of junctions and their functions.

Authors:  Heather Francis; Lindsey Kennedy; Gianfranco Alpini
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

Review 6.  Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology.

Authors:  Jacquelyn O Russell; Satdarshan P Monga
Journal:  Annu Rev Pathol       Date:  2017-11-10       Impact factor: 23.472

Review 7.  β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.

Authors:  Satdarshan Pal Monga
Journal:  Gastroenterology       Date:  2015-03-05       Impact factor: 22.682

Review 8.  The canonical way to make a heart: β-catenin and plakoglobin in heart development and remodeling.

Authors:  Oksana O Piven; Cecilia L Winata
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-18

9.  Identification of β-catenin-interacting proteins in nuclear fractions of native rat collecting duct cells.

Authors:  Jacqueline R Hwang; Chung-Lin Chou; Barbara Medvar; Mark A Knepper; Hyun Jun Jung
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-15

Review 10.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.